IBInes Brajac

Ines Brajac

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ines Brajac has a total of 131 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pityriasis rubra pilaris following booster dose of mRNA (Pfizer– BioNTech ) COVID ‐19 vaccine

    by Nika Hlaca, Tina Zagar, Marija Kastelan, Sandra Peternel, Ines Brajac, Katarina Dujmovic‐Hasanbegovic, Larisa Prpic‐Massari


  • New‐onset lichen planus and lichen planus flare in elderly women after COVID ‐19 vaccination

    by Nika Hlaca, Tina Zagar, Marija Kastelan, Sandra Peternel, Ines Brajac, Larisa Prpic‐Massari


    • 1 January 2018
      • Vol. 26  (2) , 173-178

    Tumor Necrosis Factor Antagonists in the Treatment of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Syndrome

    by Valentina Saint-Georges, Sandra Peternel, Marija Kastelan, Ines Brajac

    The clinical triad of pyoderma gangrenosum (PG), acne and suppurative hidradenitis (HS) has been described under the acronym PASH syndrome and is considered to represent a distinct entity in the group of autoinflammatory diseases. It is a fairly new, only recently recognized disorder with a limited number of reported cases and without defined treatment recommendations. We aimed to summarize currently available data on the use of tumor necrosis factor (TNF) antagonists in the management of PASH syndrome and report on our own experience with the use of adalimumab in a patient presenting with this specific constellation of clinical signs and symptoms. Among the 11 cases identified in the literature, infliximab and adalimumab were the most commonly used agents, both exhibiting favorable effects in the majority of, but not all, patients. This was particularly evident in terms of relatively rapid remission of PG whereas HS lesions seemed to be more resistant to treatment. In our patient, adalimumab monotherapy resulted in a remarkable and sustained remission, although significant improvement of HS lesions was observed only from week 16 of therapy onwards. In summary, TNF antagonists are a promising treatment for PASH; however, conclusions regarding the choice of a specific agent, optimal dosing or use in combination with other treatment modalities cannot yet be drawn.


    • 1 March 2016
      • Vol. 28  (1) , 34-8

    Satisfaction with life and coping skills in the acute and chronic urticaria.

    by Sandra Blazevic Zelic, Gordana Rubeša, Ines Brajac, Marija Vučić Peitl, Eduard Pavlović

    The purpose of this study was to examine the differences in satisfaction with life and coping strategies between patients with acute and chronic urticaria. Sixty patients with urticaria were divided into 2 groups after 6 weeks of standardized dermatology treatment (33 patients with acute and 27 patients with chronic urticaria). At baseline, all patients answered the following questionnaires: Satisfaction with Life Scale (SWLS), Personal Wellbeing Index (PWI-A), The Multidimensional Coping Inventory (COPE) and General questionnaire (age, gender, education, employment, marital status). After six weeks all the participants were re-tested with 2 questionnaires: SWLS and PWI-A. Six weeks after the initial testing there was a statistically significant difference in satisfaction with life between patients with acute and chronic urticaria. Patients with acute urticaria were more satisfied with their lives than patients with chronic urticaria. Also, there was a statistically significant difference in the use of emotion-focused coping, seeking social support for emotional reasons and seeking social support for instrumental reasons. Patients with acute urticaria used emotion-focused coping and sought social support for emotional and instrumental reasons to a greater degree than patients with chronic urticaria. Patients with acute urticaria were more satisfied with their lives than patients with chronic urticaria. Patients with acute urticaria used emotion-focused coping and sought social support for emotional and instrumental reasons to a greater degree than patients with chronic urticaria.


  • Cytotoxic T lymphocytes as a potential brake of keratinocyte proliferation in psoriasis

    by Marijana Vičić, Sandra Peternel, Edita Simonić, Vlatka Sotošek-Tokmadžić, Dražen Massari, Ines Brajac, Marija Kaštelan, Larisa Prpić-Massari


    • 1 January 2014
      • Vol. 22  (3) , 175-9

    Dermatophyte Infections in Primorsko-Goranska County, Croatia: a 21-year Survey.

    by Marija Kaštelan, Vesna Utješinović-Gudelj, Larisa Prpić Massari, Ines Brajac

    This study examined the frequency of dermatophytoses in the Primorsko-Goranska County, a north-western part of Croatia, over a period of 21 years (1988-2008). All fungal samples were microscopically examined with 20% potassium hydroxide (KOH) solution. Fungal infections were confirmed in 26.9% cases. Out of these, dermatophytes were isolated in 38.3%, Candida spp. infection in 55.1% cases, while non-dermatophyte molds were identified in 6.6% isolates. The most frequently isolated dermatophyte was Trichophyton (T.) mentagrophytes var. interdigitalis (55.4%), followed by Mycrosporum (M.) canis (36.9%), T. violaceum (3.2%), M. gypseum (2.2%), and T. verrucosum (1.3%). Epidermophyton (E.) floccosum (0.9%) and T. rubrum (0.1%) were identified only sporadically. The most common dermatophytosis diagnosed in the 21-year period was tinea pedis (26.2%) followed by tinea capitis (21.8%) and tinea corporis (20.1%). Toenail onychomycosis (14.5%) was more common than fingernail onychomycosis (2.0%). T. mentagrophytes var. interdigitalis was the major pathogen causing tinea pedis (86.6%) as well as toenail onychomycosis (93.9%), while M. canis was most frequently isolated in tinea capitis (98.6%), tinea corporis (62.1%), and tinea faciei (40.2%). With regard to age and sex, T. mentagrophytes var. interdigitalis infections were predominant in middle-aged men. M. canis affected mostly children up to 9 years with a slight predominance in girls. Data from epidemiological trend analysis such as presented in our study are important for evidence-based public health measures for the prevention and control of dermatophytoses.


    • 3 September 2013
      • Vol. 135, 195-200

    [Guidelines for the diagnosis and treatment of psoriasis].

    by Marija Kastelan, Neira Puizina-Ivić, Romana Ceović, Zlatica Jukić, Vedrana Bulat, Edita Simonić, Larisa Prpić Massari, Ines Brajac, Gordana Krnjević Pezić

    Croatian dermatovenerological society of the Croatian Medical Association formed the working group which consists of leading experts for psoriasis in Croatia. After a critical analysis of relevant scientific papers, the working group has developed guidelines for the diagnosis and treatment of psoriasis.

  • Adverse reactions and alleged allergy to local anesthetics: Analysis of 331 patients

    by Tanja Batinac, Vlatka Sotošek Tokmadžić, Vesna Peharda, Ines Brajac

    The aim of this study was to determine the prevalence of true local anesthetic (LA) allergy among patients referred for suspected hypersensitivity and to describe the main characteristics of adverse drug reactions (ADR) induced byLAin our population. We retrospectively analyzed the medical files of patients referred to the Department of Dermatovenereology, University Hospital Center Rijeka,Rijeka,Croatia, for the investigation ofLAhypersensitivity in the period betweenJanuary 2000 andDecember 2012. A total of 331 patients underwent skin testing and, in cases of negative results, subcutaneous exposition toLA. In patients with suspected delayed reaction, patch test was performed. Altogether, 331 patients reported 419 independentADRoccurring during 346 procedures. Most commonly, patients reported having only oneADR, but 41 (12.4%) of them had two reactions, 14 (4.2%) had three, five (1.5%) had four and in one patient (0.3%) fiveADRtoLAwere observed. The majority of reactions occurred during dental procedures when most commonly lidocaine and articaine were used. Local reactions were reported in 44 patients, whereas 490 general symptoms occurred during 375 independentADRin 287 patients. The most common symptoms were cardiovascular system reactions in 89 patients (18.2%). Allergic reaction was detected in three patients (0.91%). One patient showed immediate‐type reaction to bupivacaine and two patients had a delayed‐type reaction to lidocaine. Adverse reactions toLAare common and are mostly due to their pharmacological properties and drug combinations or psychogenic origin. Allergic accidents toLAare rare.


  • Expression of TWEAK in normal human skin, dermatitis and epidermal neoplasms: association with proliferation and differentiation of keratinocytes

    by Sandra Peternel, Teo Manestar-Blažić, Ines Brajac, Larisa Prpić-Massari, Marija Kaštelan

    Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) has been implicated in the pathogenesis of various inflammatory pathologies and cancer. We aimed to investigate its expression in normal human skin, inflammatory skin diseases and epidermal neoplasms. Immunohistochemistry for TWEAK was performed in samples of healthy skin, plaque psoriasis, lichen planus, prurigo nodularis, discoid lupus erythematosus, lichen sclerosus, seborrheic keratosis, common warts, actinic keratosis, Bowen's disease, keratoacanthoma and basal and squamous cell carcinoma. Double immunofluorescence was used to investigate co-localization of TWEAK with cytokeratin-10 and proliferating cell nuclear antigen (PCNA). TWEAK was robustly expressed in the epidermis of healthy skin and decreased in inflammatory conditions, both in the context of epidermal hyperplasia and atrophy. Decreased TWEAK immunoreactivity was regularly observed in common warts, actinic keratosis and Bowen's disease, particularly in areas of marked proliferation as evidenced by PCNA-positive nuclei. In squamous cell carcinoma, expression of TWEAK ranged from strong to completely absent, and it mostly corresponded with the expression of cytokeratin-10. TWEAK was absent in keratoacanthoma and basal cell carcinoma. TWEAK is a constitutively expressed epidermal protein whose downregulation might be an early indicator of disturbed differentiation or pathologic proliferation of keratinocytes that accompany inflammatory and neoplastic skin diseases.


    • 8 February 2011
      • Vol. 132, 365-9

    [Treatment of alopecia areata: modern principles and perspectives].

    by Ines Brajac, Marija Kastelan, Darinka Perisa, Edita Simonić, Lilijana Stojnić-Sosa, Larisa Prpić Massari

    Alopecia areata (AA) is a frequent disease with nonscarring hair loss on the scalp and/or body. Hair follicle in alopecia areata is not irreversibly destroyed, so potential for hair regrowth remains. Considering unknown etiopathogenesis, treatment of AA is symptomatic and directed toward halting disease activity. Lymphocytic inflammatory infiltrate around hair follicle, increased levels of autoantibodies, cytokine abnormalities and increased prevalence of autoimmune comorbidities, support the hypothesis of AA as an organ-specific autoimmune disorder. Therefore, investigations are directed toward new immunomodulatory or immunosuppressive drugs with induction effect on hair growth. New biologic drugs and their influence on hair growth as well as genetic therapy for alopecia areata are currently under investigation. Contemporary principles in therapy of alopecia areata and treatments available will be discussed in this article.